Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

The European Commission Approved Merck's Winrevair (Sotatercept), In Combination With Other Pulmonary Arterial Hypertension (PAH) Therapies, For PAH In Adult Patients With World Health Organization Functional Class II To III, To Improve Exercise Capacity

Author: Benzinga Newsdesk | August 26, 2024 06:49am

Posted In: MRK